| Etiology of aseptic meningitis and encephalitis in an adult population L Kupila, T Vuorinen, R Vainionpaa, V Hukkanen, RJ Marttila, ... Neurology 66 (1), 75-80, 2006 | 468 | 2006 |
| Herpesviruses in brains in Alzheimer's and Parkinson's diseases N Hemling, M Röyttä, J Rinne, P Pöllänen, E Broberg, V Tapio, ... Annals of neurology 54 (2), 267-271, 2003 | 146 | 2003 |
| Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland H Peltola, T Kurki, M Virtanen, M Nissinen, V Karanko, V Hukkanen, ... The Lancet 327 (8473), 137-139, 1986 | 131 | 1986 |
| Herpes simplex virus type 1 Us3 gene deletion influences toll-like receptor responses in cultured monocytic cells P Peri, RK Mattila, H Kantola, E Broberg, HS Karttunen, M Waris, ... Virology journal 5, 1-11, 2008 | 108 | 2008 |
| Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection OV Denisova, L Kakkola, L Feng, J Stenman, A Nagaraj, J Lampe, ... Journal of Biological Chemistry 287 (42), 35324-35332, 2012 | 102 | 2012 |
| Novel antiviral activities of obatoclax, emetine, niclosamide, brequinar, and homoharringtonine PI Andersen, K Krpina, A Ianevski, N Shtaida, E Jo, J Yang, S Koit, ... Viruses 11 (10), 964, 2019 | 92 | 2019 |
| Semliki Forest virus infects mouse brain endothelial cells and causes blood-brain barrier damage M Soilu-Hänninen, JP Erälinna, V Hukkanen, M Röyttä, AA Salmi, ... Journal of virology 68 (10), 6291-6298, 1994 | 88 | 1994 |
| Expression of the herpes simplex virus 1 alpha transinducing factor (VP16) does not induce reactivation of latent virus or prevent the establishment of latency in mice AE Sears, V Hukkanen, MA Labow, AJ Levine, B Roizman Journal of virology 65 (6), 2929-2935, 1991 | 88 | 1991 |
| The N-myc proto-oncogene and IGF-II growth factor mRNAs are expressed by distinct cells in human fetal kidney and brain. H Hirvonen, M Sandberg, H Kalimo, V Hukkanen, E Vuorio, TT Salmi, ... The Journal of cell biology 108 (3), 1093-1104, 1989 | 77 | 1989 |
| Novel activities of safe-in-human broad-spectrum antiviral agents A Ianevski, E Zusinaite, S Kuivanen, M Strand, H Lysvand, M Teppor, ... Antiviral research 154, 174-182, 2018 | 76 | 2018 |
| In vitro establishment of lytic and nonproductive infection by herpes simplex virus type 1 in three-dimensional keratinocyte culture S Syrjänen, H Mikola, M Nykänen, V Hukkanen Journal of virology 70 (9), 6524-6528, 1996 | 68 | 1996 |
| Detection of Chlamydia truehornatis in Clinical Specimens by Nucleic Acid Spot Hybridization T HYYPIÄ, A JALAVA, SH LARSEN, P TERHO, V HUKKANEN Microbiology 131 (4), 975-978, 1985 | 65 | 1985 |
| Time-resolved fluorometry PCR assay for rapid detection of herpes simplex virus in cerebrospinal fluid V Hukkanen, T Rehn, R Kajander, M Sjöroos, M Waris Journal of clinical microbiology 38 (9), 3214-3218, 2000 | 60 | 2000 |
| Personalized cancer vaccine platform for clinically relevant oncolytic enveloped viruses E Ylösmäki, C Malorzo, C Capasso, O Honkasalo, M Fusciello, B Martins, ... Molecular Therapy 26 (9), 2315-2325, 2018 | 54 | 2018 |
| Expression of interleukin-4 but not of interleukin-10 from a replicative herpes simplex virus type 1 viral vector precludes experimental allergic encephalomyelitis E Broberg, N Setälä, M Röyttä, A Salmi, JP Erälinna, B He, B Roizman, ... Gene therapy 8 (10), 769-777, 2001 | 54 | 2001 |
| Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread H Välimaa, J Tenovuo, M Waris, V Hukkanen Virology Journal 6, 1-7, 2009 | 52 | 2009 |
| Cathepsins are involved in virus-induced cell death in ICP4 and Us3 deletion mutant herpes simplex virus type 1-infected monocytic cells P Peri, K Nuutila, T Vuorinen, P Saukko, V Hukkanen Journal of general virology 92 (1), 173-180, 2011 | 51 | 2011 |
| Low copy number detection of herpes simplex virus type 1 mRNA and mouse Th1 type cytokine mRNAs by Light Cycler quantitative real-time PCR EK Broberg, M Nygårdas, AA Salmi, V Hukkanen Journal of virological methods 112 (1-2), 53-65, 2003 | 51 | 2003 |
| Anticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected mice L Kakkola, OV Denisova, J Tynell, J Viiliäinen, T Ysenbaert, RC Matos, ... Cell Death & Disease 4 (7), e742-e742, 2013 | 49 | 2013 |
| Antiviral properties of chemical inhibitors of cellular anti-apoptotic Bcl-2 proteins D Bulanova, A Ianevski, A Bugai, Y Akimov, S Kuivanen, H Paavilainen, ... Viruses 9 (10), 271, 2017 | 48 | 2017 |
